Deepak Virbhadra Kabbur

Deepak Virbhadra Kabbur

Active Director Director DIN 08024890
DIN 08024890 First appointment Nov 2017 Primary industry Machinery and Equipment
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Total affiliations 5 Since Nov 2017
Shareholding value •••• Premium profile

About Deepak Virbhadra Kabbur

Data last updated:

Deepak Virbhadra Kabbur is a Director at Brio Pharma Technologies Private Limited (since 2021), Director at Ibc Pharmaceuticals Private Limited (since 2017) and Additional Director at Brio Packaging Private Limited (since 2018), and holds 2 more current directorships. The companies operate in Machinery and Equipment, Chemicals and Materials and Business Services. The 3 current companies with reported revenue have a combined latest revenue of ₹11.28 Cr; the largest is Brio Pharma Technologies Private Limited at ₹9.96 Cr (FY 2025).

DIN 08024890
Primary Designation Director
Industry Machinery and Equipment
First Appointment 29 Nov 2017
Oldest Company Age 21 yrs
Largest company Brio Pharma Technologies Private Limited · ₹9.96 Cr (FY 2025)
Combined revenue ₹11.28 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Aug 20212005₹9.96 Cr (FY 2025)Active
Ibc Pharmaceuticals Private Limited U24239MH2011PTC215791
Director29 Nov 20172011₹94 Lakh (FY 2025)Active
Brio Packaging Private Limited U74900MH2013PTC241933
Additional Director06 Mar 20182013₹38.5 Lakh (FY 2023)Active
Director22 Jul 20252025Active
Director01 Mar 20242024Active

Directorship timeline

Open interactive timeline →
Ibc Pharmaceuticals Private Limited
Brio Pharma Technologies Private Limited
Brio Packaging Private Limited
Demogen Global Capability Center India Private Limited
Premium access

Shareholding and investment profile for Deepak Virbhadra Kabbur

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Deepak Virbhadra Kabbur

Deepak Virbhadra Kabbur currently holds 5 directorships: Brio Pharma Technologies Private Limited (Director, since 11 Aug 2021, revenue ₹9.96 Cr (FY 2025)); Ibc Pharmaceuticals Private Limited (Director, since 29 Nov 2017, revenue ₹94 Lakh (FY 2025)); Brio Packaging Private Limited (Additional Director, since 06 Mar 2018, revenue ₹38.5 Lakh (FY 2023)); Demogen Global Capability Center India Private Limited (Director, since 22 Jul 2025); Promedica Pharmaceuticals Private Limited (Director, since 01 Mar 2024).

Deepak Virbhadra Kabbur was first appointed on 29 Nov 2017 as Director at Ibc Pharmaceuticals Private Limited. The most recent appointment on record is 22 Jul 2025 at Demogen Global Capability Center India Private Limited.

The 3 current companies of Deepak Virbhadra Kabbur that report revenue have a combined latest revenue of ₹11.28 Cr: Brio Pharma Technologies Private Limited ₹9.96 Cr (FY 2025); Ibc Pharmaceuticals Private Limited ₹94 Lakh (FY 2025); Brio Packaging Private Limited ₹38.5 Lakh (FY 2023).

The current boards of Deepak Virbhadra Kabbur's companies include Deelish Narayanan Kapadan (Brio Pharma Technologies Private Limited), Mithila Shubham Mishra (Brio Pharma Technologies Private Limited), Shubham Suresh Mishra (Brio Pharma Technologies Private Limited), Kranthikiran Siddappa (Ibc Pharmaceuticals Private Limited), Rajeev Virbhadra Kabbur (Ibc Pharmaceuticals Private Limited), Ravindranath Tagore Talasila (Ibc Pharmaceuticals Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available